View in EDS HTML Full Text PDF Full Text

Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.

Saved in:
Bibliographic Details
Title: Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
Authors: van Bilsen K; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Vergouwen DPC; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Velthoven MEJ; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Missotten TOAR; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Rombach SM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Zelm MC; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology and Pathology, Central Clinical School, Monash University and Alfred Hospital, Melbourne, Australia., Berkowska MA; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van Hagen PM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Kuijpers RWAM; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Ophthalmology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., van Laar JAM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Sep; Vol. 32 (7), pp. 1268-1273. Date of Electronic Publication: 2023 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37437135
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Bilsen+K%22">van Bilsen K</searchLink>; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vergouwen+DPC%22">Vergouwen DPC</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Velthoven+MEJ%22">van Velthoven MEJ</searchLink>; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Missotten+TOAR%22">Missotten TOAR</searchLink>; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rombach+SM%22">Rombach SM</searchLink>; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Zelm+MC%22">van Zelm MC</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology and Pathology, Central Clinical School, Monash University and Alfred Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Berkowska+MA%22">Berkowska MA</searchLink>; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Hagen+PM%22">van Hagen PM</searchLink>; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuijpers+RWAM%22">Kuijpers RWAM</searchLink>; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Ophthalmology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22van+Laar+JAM%22">van Laar JAM</searchLink>; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229312169%22">Ocular immunology and inflammation</searchLink> [Ocul Immunol Inflamm] 2024 Sep; Vol. 32 (7), pp. 1268-1273. <i>Date of Electronic Publication: </i>2023 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9312169 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-5078 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209273948%22">09273948 </searchLink><i>NLM ISO Abbreviation: </i>Ocul Immunol Inflamm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37437135
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09273948.2023.2229900
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1268
    Titles:
      – TitleFull: Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Bilsen K
      – PersonEntity:
          Name:
            NameFull: Vergouwen DPC
      – PersonEntity:
          Name:
            NameFull: van Velthoven MEJ
      – PersonEntity:
          Name:
            NameFull: Missotten TOAR
      – PersonEntity:
          Name:
            NameFull: Rombach SM
      – PersonEntity:
          Name:
            NameFull: van Zelm MC
      – PersonEntity:
          Name:
            NameFull: Berkowska MA
      – PersonEntity:
          Name:
            NameFull: van Hagen PM
      – PersonEntity:
          Name:
            NameFull: Kuijpers RWAM
      – PersonEntity:
          Name:
            NameFull: van Laar JAM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1744-5078
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Ocular immunology and inflammation
              Type: main
ResultId 1